107 related articles for article (PubMed ID: 16476811)
1. Relation of quantitative indexes of concurrent alpha-synuclein abnormalities to clinical outcome in autopsy-proven Alzheimer disease.
Holtzer R; Irizarry MC; Sanders J; Hyman BT; Wegesin DJ; Riba A; Brandt J; Albert M; Stern Y
Arch Neurol; 2006 Feb; 63(2):226-30. PubMed ID: 16476811
[TBL] [Abstract][Full Text] [Related]
2. Cognitive status correlates with neuropathologic stage in Parkinson disease.
Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
[TBL] [Abstract][Full Text] [Related]
3. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
[TBL] [Abstract][Full Text] [Related]
4. Clinical phenotype of Parkinson disease dementia.
Galvin JE; Pollack J; Morris JC
Neurology; 2006 Nov; 67(9):1605-11. PubMed ID: 17101891
[TBL] [Abstract][Full Text] [Related]
5. A critical reappraisal of current staging of Lewy-related pathology in human brain.
Jellinger KA
Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
[TBL] [Abstract][Full Text] [Related]
6. Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years.
Ranginwala NA; Hynan LS; Weiner MF; White CL
Am J Geriatr Psychiatry; 2008 May; 16(5):384-8. PubMed ID: 18448850
[TBL] [Abstract][Full Text] [Related]
7. An investigation of clinical correlates of Lewy bodies in autopsy-proven Alzheimer disease.
Stern Y; Jacobs D; Goldman J; Gomez-Tortosa E; Hyman BT; Liu Y; Troncoso J; Marder K; Tang MX; Brandt J; Albert M
Arch Neurol; 2001 Mar; 58(3):460-5. PubMed ID: 11255450
[TBL] [Abstract][Full Text] [Related]
8. Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease.
Lopez OL; Becker JT; Sweet RA; Martin-Sanchez FJ; Hamilton RL
Neurology; 2006 Aug; 67(4):660-5. PubMed ID: 16924019
[TBL] [Abstract][Full Text] [Related]
9. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha GA; Parisi JE; Dickson DW; Johnson K; Cha R; Ivnik RJ; Tangalos EG; Boeve BF; Knopman DS; Braak H; Petersen RC
Arch Neurol; 2006 May; 63(5):674-81. PubMed ID: 16682537
[TBL] [Abstract][Full Text] [Related]
10. Cognitive measures predict pathologic Alzheimer disease.
Powell MR; Smith GE; Knopman DS; Parisi JE; Boeve BF; Petersen RC; Ivnik RJ
Arch Neurol; 2006 Jun; 63(6):865-8. PubMed ID: 16769868
[TBL] [Abstract][Full Text] [Related]
11. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
[TBL] [Abstract][Full Text] [Related]
12. Can alzheimer's disease and dementias with Lewy bodies be distinguished clinically?
Weiner MF; Hynan LS; Parikh B; Zaki N; White CL; Bigio EH; Lipton AM; Martin-Cook K; Svetlik DA; Cullum CM; Vobach S; Rosenberg RN
J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):245-50. PubMed ID: 14653435
[TBL] [Abstract][Full Text] [Related]
13. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.
Oinas M; Sulkava R; Polvikoski T; Kalimo H; Paetau A
APMIS; 2007 Jul; 115(7):820-7. PubMed ID: 17614849
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
Jellinger KA; Attems J
Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
[TBL] [Abstract][Full Text] [Related]
15. CSF alpha-synuclein levels in dementia with Lewy bodies and Alzheimer's disease.
Noguchi-Shinohara M; Tokuda T; Yoshita M; Kasai T; Ono K; Nakagawa M; El-Agnaf OM; Yamada M
Brain Res; 2009 Jan; 1251():1-6. PubMed ID: 19071095
[TBL] [Abstract][Full Text] [Related]
16. Lewy bodies and progressive dementia: a critical review and meta-analysis.
Cercy SP; Bylsma FW
J Int Neuropsychol Soc; 1997 Mar; 3(2):179-94. PubMed ID: 9126859
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
18. Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
Bombois S; Maurage CA; Gompel M; Deramecourt V; Mackowiak-Cordoliani MA; Black RS; Lavielle R; Delacourte A; Pasquier F
Arch Neurol; 2007 Apr; 64(4):583-7. PubMed ID: 17420322
[TBL] [Abstract][Full Text] [Related]
19. The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer disease.
Holtzer R; Wegesin DJ; Albert SM; Marder K; Bell K; Albert M; Brandt J; Stern Y
Arch Neurol; 2003 Aug; 60(8):1137-42. PubMed ID: 12925372
[TBL] [Abstract][Full Text] [Related]
20. Essential tremor associated with focal nonnigral Lewy bodies: a clinicopathologic study.
Louis ED; Honig LS; Vonsattel JP; Maraganore DM; Borden S; Moskowitz CB
Arch Neurol; 2005 Jun; 62(6):1004-7. PubMed ID: 15956174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
